BioCentury
ARTICLE | Company News

Grifols, Talecris deal

June 13, 2011 7:00 AM UTC

Grifols completed its previously announced acquisition of fellow plasma protein company Talecris in a cash and stock deal that the companies said values Talecris at $26.16 per share, or about $3.4 bil...